Combine lifestyle measures with drug treatment

Obesity is on the rise worldwide and is one of the greatest public health challenges of our time. In addition to dietary changes and exercise, GLP-1 agonists are a new tool in the repertoire of individualized obesity therapy. New study data show that durable weight control can be achieved through multimodal combination therapy.